Molecular Diagnostics Sales Propel Strong Q1 Results for Myriad Genetics

Nov 04, 2008

NEW YORK (GenomeWeb News) – Myriad Genetics today reported 53 percent revenue growth and a swing from a net loss to a profit for its first quarter ended Sept. 30.

The Salt Lake City-based firm brought in total revenues of $73.6 million for the quarter compared to $48.3 million for the comparable period of 2007. Its molecular diagnostics sales jumped 52 percent to $70 million from $46.1 million, and its research and other revenue increased 68 percent to $3.7 million from $2.2 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

The Same Genes Keep Getting Asked to Prom

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

Keep Them in the Know

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

From Tusk to Cartel

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

This Week in Nature

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.

Main menu